IN-VITRO DEMONSTRATION OF A FUNDAMENTAL DIFFERENCE IN THE PROLIFERATION OF MURINE AND HUMAN BONE-MARROW AND LYMPHOCYTES FOLLOWING ULTRAVIOLET-IRRADIATION - RELEVANCE TO BONE-MARROW TRANSPLANTATION

被引:3
作者
HUDSON, JG [1 ]
PULLENS, R [1 ]
GODWIN, V [1 ]
PREECE, AW [1 ]
PAMPHILON, DH [1 ]
机构
[1] BRISTOL ONCOL CTR, BRISTOL BS2 8ED, AVON, ENGLAND
关键词
D O I
10.1111/j.1751-1097.1995.tb02386.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Exposure of rodent allogeneic donor marrow and splenocyte grafts to ultraviolet radiation (UVR) has been shown to permit durable engraftment at doses that abolish graft-versus-host disease (GVHD) and graft rejection. We have compared both murine and human alloreactive and mitogen-induced lymphoid responses and bone marrow proliferation in mixed lymphocyte culture (MLC), phytohemagglutinin (PHA)-induced proliferation and colony-forming unit-granulocyte/macrophage (CFU-GM) assays using germicidal UVC (200-290 nm), broadband and narrowband UVB (290-320 nm) and UVA (320-400 nm) sources. Our data show a wavelength and dose-dependent reduction in lymphoid proliferation in the mouse with CFU-GM survival of 50-75% of control at doses required to abolish allogeneic lymphocyte responses for all lamps. In contrast, human lymphocyte responses are more resistant to UVC with CFU-GM proliferation reduced to zero when allostimulation is abolished. Mitogen-induced lymphoid responses show a similar wavelength-dependent sensitivity. Abolition of response in MLC using UV-irradiated stimulator cells was less sensitive than proliferation with UV-irradiated responder cells at all wavelengths in both species. With all sources, murine CFU-GM proliferation is less susceptible to UVR than human marrow at doses required to abolish lymphoid responses.
引用
收藏
页码:568 / 574
页数:7
相关论文
共 35 条
[1]   REGIMEN-RELATED TOXICITY AND EARLY POSTTRANSPLANT SURVIVAL IN PATIENTS UNDERGOING MARROW TRANSPLANTATION FOR LYMPHOMA [J].
BEARMAN, SI ;
APPELBAUM, FR ;
BACK, A ;
PETERSEN, FB ;
BUCKNER, CD ;
SULLIVAN, KM ;
SCHOCH, HG ;
FISHER, LD ;
THOMAS, ED .
JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (09) :1288-1294
[2]   INCREASING UTILIZATION OF BONE-MARROW TRANSPLANTATION .2. RESULTS OF THE 1985-1987 SURVEY [J].
BORTIN, MM ;
RIMM, AA .
TRANSPLANTATION, 1989, 48 (03) :453-458
[3]   UVB PRETREATMENT OF RAT BONE-MARROW ALLOGRAFTS - PREVENTION OF GVHD AND INDUCTION OF ALLOCHIMERISM AND DONOR-SPECIFIC UNRESPONSIVENESS [J].
CHABOT, JA ;
PEPINO, P ;
WASFIE, T ;
STEGALL, MD ;
MARBOE, C ;
HARDY, MA .
TRANSPLANTATION, 1990, 49 (05) :886-889
[4]  
COHN ML, 1991, BLOOD, V78, P3317
[5]  
DEEG HJ, 1989, TRANSPLANT P, V21, P2938
[6]  
DEEG HJ, 1989, BLOOD, V73, P369
[7]  
DEEG HJ, 1988, BLOOD, V71, P1138
[8]   ULTRAVIOLET-IRRADIATION IN TRANSPLANTATION BIOLOGY - MANIPULATION OF IMMUNITY AND IMMUNOGENICITY [J].
DEEG, HJ .
TRANSPLANTATION, 1988, 45 (05) :845-851
[9]   EVIDENCE THAT REDUCTION OF IMMUNOGENICITY OF T-DEPLETED BONE-MARROW DEPENDS ON ADDITIONAL DEPLETION OF ACCESSORY CELLS - IMPLICATIONS FOR PREVENTION OF GRAFT-REJECTION [J].
DREGER, P ;
MULLERRUCHHOLTZ, W .
TRANSPLANTATION, 1990, 49 (03) :622-630
[10]   COMPARATIVE POTENCY OF DIFFERENT UV SOURCES IN REDUCING THE DENSITY AND ANTIGEN-PRESENTING CAPACITY OF LANGERHANS CELLS IN C3H MICE [J].
ELGHORR, AA ;
PIERIK, F ;
NORVAL, M .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 1994, 60 (03) :256-261